Kalin Health
CompanyUnited States
Kalin Health develops one asset, in human trials (KH-1 in aging). Mostly supplement acting on autophagy; based in the United States.
- 1
- Asset
- Furthest stage
- Human trials
- 1
- Trial
- 0
- Signals
Pipeline
1Dietary polyamine supplement intended to stimulate autophagy
Human trials, Supplement, Autophagy, aging, prediabetes
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Similar companies6